TCL Archive In Brief: Oliverio Moves to DEA; Kushner Blass NIH Slow Pay; DeVita Welcomes Hawkin’s Probe February 6, 1981
TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
TCL Archive Recalcitrant Cancer Bill Heading To Senate May Face Hold in the Lame Duck Session November 16, 2012
TCL Archive Taxol Plus Carboplatin Increased Survival Of NSCLC In Patients 70 And Older June 25, 2010
